title: Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions.
abstract: Adeno-associated virus (AAV) vectors are one of the most efficient in vivo gene delivery platforms. Over the past decade, clinical trials of AAV vector-mediated gene transfer led to some of the most exciting results in the field of gene therapy and, recently, to the market approval of an AAV-based drug in Europe. With clinical development, however, it became obvious that the host immune system represents an important obstacle to successful gene transfer with AAV vectors. In this review article, we will discuss the issue of cytotoxic T cell responses directed against the AAV capsid encountered on human studies. While over the past several years the field has acquired a tremendous amount of information on the interactions of AAV vectors with the immune system, a lot of questions are still unanswered. Novel concepts are emerging, such as the relationship between the total capsid dose and the T cell-mediated clearance of transduced cells, the potential role of innate immunity in vector immunogenicity highlighted in preclinical studies, and the cross talk between regulatory and effector T cells in the determination of the outcome of gene transfer. There is still a lot to learn about immune responses in AAV gene transfer, for example, it is not well understood what are the determinants of the kinetics of activation of T cells in response to vector administration, why not all subjects develop detrimental T cell responses following gene transfer, and whether the intervention strategies currently in use to block T cell-mediated clearance of transduced cells will be safe and effective for all gene therapy indications. Results from novel preclinical models and clinical studies will help to address these points and to reach the important goal of developing safe and effective gene therapy protocols to treat human diseases.
authors.affiliation: Department of Hematology, The Children's Hospital of Philadelphia , Philadelphia, PA , USA.
authors.forename: Etiena
authors.initials: E
authors.lastname: Basner-Tschakarjan
authors.affiliation: University Pierre and Marie Curie , Paris , France ; Genethon , Evry , France.
authors.forename: Federico
authors.initials: F
authors.lastname: Mingozzi
keywords: AAV vectors; T cell responses; gene therapy; immune modulation; immunogenicity
references.citation: Blood. 2014 May 15;123(20):3195-9
references.pmid: 24637359
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11854-9
references.pmid: 12192090
references.citation: J Immunol. 2012 Jul 1;189(1):146-53
references.pmid: 22634621
references.citation: J Clin Invest. 2000 Jun;105(11):1573-87
references.pmid: 10841516
references.citation: Nat Med. 2007 Apr;13(4):419-22
references.pmid: 17369837
references.citation: Science. 1965 Aug 13;149(3685):754-6
references.pmid: 14325163
references.citation: N Engl J Med. 2009 Jan 29;360(5):447-58
references.pmid: 19179314
references.citation: Mol Ther. 2001 Sep;4(3):201-10
references.pmid: 11545610
references.citation: Sci Transl Med. 2013 Jul 17;5(194):194ra92
references.pmid: 23863832
references.citation: Hepatology. 2012 Jan;55(1):287-97
references.pmid: 21898480
references.citation: Mol Immunol. 2013 Sep;55(2):113-6
references.pmid: 23183105
references.citation: J Virol. 2002 May;76(9):4580-90
references.pmid: 11932423
references.citation: J Clin Invest. 2013 Mar;123(3):1390-401
references.pmid: 23454772
references.citation: Blood. 2013 May 23;121(21):4396-403
references.pmid: 23372167
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8
references.pmid: 19706466
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7827-32
references.pmid: 18511559
references.citation: Front Immunol. 2014 Mar 03;5:82
references.pmid: 24624131
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15112-7
references.pmid: 18809924
references.citation: J Clin Invest. 2013 Dec;123(12):5310-8
references.pmid: 24231351
references.citation: PLoS One. 2009 Aug 04;4(8):e6376
references.pmid: 19652717
references.citation: Lancet. 2007 Jun 23;369(9579):2097-105
references.pmid: 17586305
references.citation: Mol Ther. 2007 Apr;15(4):792-800
references.pmid: 17245353
references.citation: Ann Neurol. 2009 Sep;66(3):290-7
references.pmid: 19798725
references.citation: Blood. 2009 Sep 3;114(10):2077-86
references.pmid: 19506302
references.citation: Blood. 2012 Mar 29;119(13):3038-41
references.pmid: 22271447
references.citation: N Engl J Med. 2010 Oct 7;363(15):1429-37
references.pmid: 20925545
references.citation: J Med Virol. 1999 Nov;59(3):406-11
references.pmid: 10502275
references.citation: Mol Ther Methods Clin Dev. 2014;1(9):20139
references.pmid: 25485285
references.citation: Gastroenterology. 2011 Jul;141(1):348-57, 357.e1-3
references.pmid: 21640112
references.citation: Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2303-4
references.pmid: 18802015
references.citation: J Virol. 2008 Mar;82(6):2727-40
references.pmid: 18199646
references.citation: Curr Gene Ther. 2011 Aug;11(4):321-30
references.pmid: 21557723
references.citation: Science. 2013 Aug 23;341(6148):1233151
references.pmid: 23845947
references.citation: EMBO Mol Med. 2013 Nov;5(11):1684-97
references.pmid: 24106222
references.citation: Mol Ther. 2011 May;19(5):876-85
references.pmid: 21245849
references.citation: Gene Ther. 2005 Jun;12(11):873-80
references.pmid: 15829993
references.citation: Am J Hum Genet. 2007 Nov;81(5):1042-9
references.pmid: 17924344
references.citation: Mol Ther. 2012 Aug;20(8):1571-81
references.pmid: 22643865
references.citation: Neurology. 2009 Nov 17;73(20):1662-9
references.pmid: 19828868
references.citation: J Gene Med. 2006 May;8(5):577-88
references.pmid: 16532510
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10220-5
references.pmid: 20479244
references.citation: J Immunol. 2012 Jun 15;188(12):6418-24
references.pmid: 22593612
references.citation: J Virol. 1998 Apr;72(4):3241-7
references.pmid: 9525651
references.citation: Lancet Neurol. 2010 Dec;9(12):1164-1172
references.pmid: 20970382
references.citation: Ann Neurol. 2010 Nov;68(5):629-38
references.pmid: 21031578
references.citation: Science. 2002 Apr 12;296(5566):301-5
references.pmid: 11951032
references.citation: Blood. 2011 Jan 20;117(3):798-807
references.pmid: 21041718
references.citation: Mol Ther. 2013 Sep;21(9):1727-37
references.pmid: 23857231
references.citation: J Clin Invest. 2009 Jun;119(6):1688-95
references.pmid: 19436115
references.citation: Mol Ther. 2010 Jul;18(7):1318-29
references.pmid: 20424599
references.citation: Lancet Neurol. 2008 May;7(5):400-8
references.pmid: 18387850
references.citation: Mol Ther. 2014 Jan;22(1):42-51
references.pmid: 24077034
references.citation: Blood. 2010 Dec 23;116(26):5842-8
references.pmid: 20876851
references.citation: Science. 2009 Nov 6;326(5954):818-23
references.pmid: 19892975
references.citation: J Virol. 2007 Jul;81(14):7540-7
references.pmid: 17475652
references.citation: Science. 2013 Aug 23;341(6148):1233158
references.pmid: 23845948
references.citation: Gene Ther. 2012 Mar;19(3):288-94
references.pmid: 21697954
references.citation: Blood. 2013 Apr 25;121(17):3335-44
references.pmid: 23426947
references.citation: J Diabetes Res. 2013;2013:621693
references.pmid: 23710469
references.citation: Blood. 2010 Jun 10;115(23):4678-88
references.pmid: 20335222
references.citation: Blood. 2012 Nov 29;120(23):4517-20
references.pmid: 23043073
references.citation: Front Immunol. 2013 Sep 12;4:273
references.pmid: 24062741
references.citation: J Card Fail. 2009 Apr;15(3):171-81
references.pmid: 19327618
references.citation: Hum Gene Ther. 2005 Aug;16(8):921-8
references.pmid: 16076250
references.citation: Blood. 2003 Apr 15;101(8):2963-72
references.pmid: 12515715
references.citation: Sci Transl Med. 2012 Dec 19;4(165):165ra163
references.pmid: 23253610
references.citation: Mol Ther. 2010 Jan;18(1):135-42
references.pmid: 19904235
references.citation: J Virol. 2002 Mar;76(5):2043-53
references.pmid: 11836382
references.citation: Hum Gene Ther. 2011 May;22(5):605-12
references.pmid: 21222531
references.citation: Nature. 2010 Sep 16;467(7313):318-22
references.pmid: 20844535
references.citation: World J Gastroenterol. 2012 Aug 28;18(32):4288-99
references.pmid: 22969191
references.citation: N Engl J Med. 2008 May 22;358(21):2240-8
references.pmid: 18441370
references.citation: Blood. 2012 Nov 29;120(23):4521-3
references.pmid: 22919027
references.citation: Gene Ther. 2005 Oct;12(19):1453-64
references.pmid: 15889137
references.citation: Proc Biol Sci. 2009 Jun 22;276(1665):2233-42
references.pmid: 19324752
references.citation: J Clin Invest. 2013 Jul 1;123(8):3254-3271
references.pmid: 23863627
references.citation: EMBO Mol Med. 2013 Jan;5(1):1-3
references.pmid: 23283747
references.citation: Mol Ther. 2012 Aug;20(8):1501-7
references.pmid: 22692496
references.citation: Mol Ther. 2006 May;13(5):967-75
references.pmid: 16442848
references.citation: EMBO Mol Med. 2013 Nov;5(11):1698-709
references.pmid: 24106230
references.citation: Hum Gene Ther. 2012 May;23(5):460-72
references.pmid: 22260439
references.citation: Blood. 2004 Aug 15;104(4):969-77
references.pmid: 15105293
references.citation: Virol J. 2013 Mar 06;10:74
references.pmid: 23497173
references.citation: Blood. 2011 Jun 16;117(24):6459-68
references.pmid: 21474674
references.citation: Nat Rev Genet. 2011 May;12(5):301-15
references.pmid: 21445084
references.citation: Blood. 2004 May 15;103(10):3700-9
references.pmid: 14701690
references.citation: Front Immunol. 2013 Oct 18;4:341
references.pmid: 24151496
references.citation: Front Microbiol. 2011 Sep 19;2:194
references.pmid: 21954398
references.citation: Blood. 2013 Mar 21;121(12):2224-33
references.pmid: 23325831
references.citation: N Engl J Med. 2011 Dec 22;365(25):2357-65
references.pmid: 22149959
references.citation: Hum Reprod. 2008 Jan;23(1):29-36
references.pmid: 17977863
references.citation: Blood. 2009 Jan 22;113(4):797-806
references.pmid: 18957684
references.citation: J Transl Med. 2014 Jan 25;12:25
references.pmid: 24460861
references.citation: Blood. 2008 Oct 15;112(8):3303-11
references.pmid: 18660382
references.citation: Gene Ther. 2013 Apr;20(4):361-9
references.pmid: 22717743
references.citation: N Engl J Med. 2008 May 22;358(21):2231-9
references.pmid: 18441371
references.citation: Neurotoxicology. 2014 Jul;43:28-35
references.pmid: 24525285
references.citation: Hum Gene Ther. 2013 May;24(5):545-53
references.pmid: 23534873
references.citation: Brain. 2012 Feb;135(Pt 2):483-92
references.pmid: 22240777
references.citation: Nat Rev Genet. 2011 May;12(5):341-55
references.pmid: 21499295
references.citation: J Clin Invest. 2013 Jul;123(7):2994-3001
references.pmid: 23778142
references.citation: Blood. 2007 Oct 1;110(7):2334-41
references.pmid: 17609423
references.citation: Gene Ther. 2009 Jan;16(1):60-9
references.pmid: 18701909
references.citation: Hum Gene Ther. 2008 May;19(5):463-74
references.pmid: 18473686
references.citation: Blood. 2007 Aug 15;110(4):1132-40
references.pmid: 17438084
references.citation: Front Immunol. 2013 Aug 30;4:261
references.pmid: 24009613
references.citation: Hum Gene Ther. 2007 Mar;18(3):185-94
references.pmid: 17324107
references.citation: Hum Gene Ther. 2011 Oct;22(10):1239-47
references.pmid: 21609134
references.citation: J Transl Med. 2012 Jun 15;10:122
references.pmid: 22704060
references.citation: J Clin Invest. 2009 Aug;119(8):2388-98
references.pmid: 19587448
references.citation: Cancer Immunol Immunother. 2011 Jan;60(1):15-22
references.pmid: 21080166
references.citation: Blood. 2009 Jan 15;113(3):538-45
references.pmid: 18566327
references.citation: Blood. 2006 Nov 15;108(10):3321-8
references.pmid: 16868252
references.citation: J Clin Invest. 2003 May;111(9):1347-56
references.pmid: 12727926
references.citation: Nat Med. 2006 Mar;12(3):342-7
references.pmid: 16474400
references.citation: Mol Ther. 2010 Jan;18(1):151-60
references.pmid: 19888197
references.citation: Hum Gene Ther. 2013 Apr;24(4):393-405
references.pmid: 23427817
references.citation: Clin Vaccine Immunol. 2011 Sep;18(9):1586-8
references.pmid: 21775517